ATC Group: A07EA02 Hydrocortisone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A07EA02 in the ATC hierarchy

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
RECTAL - Rectal
0.1 g

Active ingredients in A07EA02

Active Ingredient
Description

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.

Related product monographs

Title
Information Source
Document Type
 
FDA, National Drug Code (US)
MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Canada (CA)

France (FR)

Ireland (IE)

New Zealand (NZ)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.